150 related articles for article (PubMed ID: 8183250)
1. Mechanisms of steric and cooperative actions of alcuronium on cardiac muscarinic acetylcholine receptors.
Proska J; Tucek S
Mol Pharmacol; 1994 Apr; 45(4):709-17. PubMed ID: 8183250
[TBL] [Abstract][Full Text] [Related]
2. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
Tucek S; Musílková J; Nedoma J; Proska J; Shelkovnikov S; Vorlícek J
Mol Pharmacol; 1990 Nov; 38(5):674-80. PubMed ID: 2233700
[TBL] [Abstract][Full Text] [Related]
3. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
[TBL] [Abstract][Full Text] [Related]
4. Competition between positive and negative allosteric effectors on muscarinic receptors.
Proska J; Tucek S
Mol Pharmacol; 1995 Oct; 48(4):696-702. PubMed ID: 7476896
[TBL] [Abstract][Full Text] [Related]
5. Complex allosteric modulation of cardiac muscarinic receptors by protamine: potential model for putative endogenous ligands.
Hu J; Wang SZ; Forray C; el-Fakahany EE
Mol Pharmacol; 1992 Aug; 42(2):311-21. PubMed ID: 1513329
[TBL] [Abstract][Full Text] [Related]
6. Influence of ligand choice on the apparent binding profile of gallamine to cardiac muscarinic receptors. Identification of three main types of gallamine-muscarinic receptor interactions.
Lee NH; el-Fakahany EE
J Pharmacol Exp Ther; 1988 Sep; 246(3):829-38. PubMed ID: 3418516
[TBL] [Abstract][Full Text] [Related]
7. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.
Krejcí A; Tucek S
Mol Pharmacol; 2001 Oct; 60(4):761-7. PubMed ID: 11562438
[TBL] [Abstract][Full Text] [Related]
8. Positive allosteric action of alcuronium on solubilized cardiac muscarinic receptors.
Musílková J; Tucek S
Neurochem Int; 1995; 27(4-5):337-43. PubMed ID: 8845734
[TBL] [Abstract][Full Text] [Related]
9. Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors.
Flynn DD; Vaishnav AA; Mash DC
Mol Pharmacol; 1992 Apr; 41(4):736-42. PubMed ID: 1569924
[TBL] [Abstract][Full Text] [Related]
10. Protection by alcuronium of muscarinic receptors against chemical inactivation and location of the allosteric binding site for alcuronium.
Jakubík J; Tucek S
J Neurochem; 1994 Nov; 63(5):1932-40. PubMed ID: 7931349
[TBL] [Abstract][Full Text] [Related]
11. Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts.
Schröter A; Tränkle C; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):512-9. PubMed ID: 11138843
[TBL] [Abstract][Full Text] [Related]
12. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors.
Tränkle C; Weyand O; Voigtländer U; Mynett A; Lazareno S; Birdsall NJ; Mohr K
Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174
[TBL] [Abstract][Full Text] [Related]
13. Selectivity of class I antiarrhythmic agents, disopyramide, pirmenol, and pentisomide for peripheral muscarinic M2 and M3 receptors.
Endou M; Hattori Y; Gando S; Kanno M
J Cardiovasc Pharmacol; 1992 May; 19(5):674-81. PubMed ID: 1381764
[TBL] [Abstract][Full Text] [Related]
14. Testing the specificity of allosteric modulators of muscarinic receptors in phylogenetically closely related histamine H1-receptors.
Franken C; Tränkle C; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):107-12. PubMed ID: 10685864
[TBL] [Abstract][Full Text] [Related]
15. Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites.
Waelbroeck M; Gillard M; Robberecht P; Christophe J
Mol Pharmacol; 1986 Oct; 30(4):305-14. PubMed ID: 3762520
[TBL] [Abstract][Full Text] [Related]
16. Binding profiles of class I antiarrhythmic agents to cardiac muscarinic receptors: competitive and allosteric interactions with the receptors and their pharmacological significance.
Endou M; Gando S; Hattori Y; Kanno M
J Pharmacol Exp Ther; 1991 Sep; 258(3):992-8. PubMed ID: 1890628
[TBL] [Abstract][Full Text] [Related]
17. Stabilization of antagonist binding to cardiac muscarinic acetylcholine receptors by gallamine and other neuromuscular blocking drugs.
Nedoma J; Tucek S; Danilov AF; Shelkovnikov SA
J Pharmacol Exp Ther; 1986 Jan; 236(1):219-23. PubMed ID: 3941394
[TBL] [Abstract][Full Text] [Related]
18. Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors.
Lanzafame A; Christopoulos A; Mitchelson F
J Pharmacol Exp Ther; 1997 Jul; 282(1):278-85. PubMed ID: 9223565
[TBL] [Abstract][Full Text] [Related]
19. Two populations of muscarinic binding sites in the chick heart distinguished by affinities for ligands and selective inactivation.
Jakubík J; Tucek S
Br J Pharmacol; 1994 Dec; 113(4):1529-37. PubMed ID: 7889311
[TBL] [Abstract][Full Text] [Related]
20. Identification of a [3H]Ligand for the common allosteric site of muscarinic acetylcholine M2 receptors.
Tränkle C; Mies-Klomfass E; Cid MH; Holzgrabe U; Mohr K
Mol Pharmacol; 1998 Jul; 54(1):139-45. PubMed ID: 9658199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
